A detailed history of Meadow Brook Investment Advisors LLC transactions in Mannkind Corp stock. As of the latest transaction made, Meadow Brook Investment Advisors LLC holds 920 shares of MNKD stock, worth $6,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares
920
Previous 920 -0.0%
Holding current value
$6,504
Previous $4.17 Million 15.21%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$3.34 - $4.29 $3,072 - $3,946
920 New
920 $3.35 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.82B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Meadow Brook Investment Advisors LLC Portfolio

Follow Meadow Brook Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meadow Brook Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meadow Brook Investment Advisors LLC with notifications on news.